A Public-Health-Based Vision for the Management and Regulation of Psychedelics
This policy article (2016) assesses the harms and benefits of psychedelics use in light of contemporary research and provides a public-health-based model for their regulation, which includes governance, supervision, set and setting controls, youth access, supply control, demand limitation, and evaluation.
Authors
- Kenneth Tupper
Published
Abstract
The Health Officers Council of British Columbia has proposed post-prohibition regulatory models for currently illegal drugs based on public health principles, and this article continues this work by proposing a model for the regulation and management of psychedelics. This article outlines recent research on psychedelic substances and the key determinants of benefit and harm from their use. It then describes a public-health-based model for the regulation of psychedelics, which includes governance, supervision, set and setting controls, youth access, supply control, demand limitation, and evaluation.
Research Summary of 'A Public-Health-Based Vision for the Management and Regulation of Psychedelics'
Introduction
Haden and colleagues situate their paper in the context of growing dissatisfaction with prohibitionist drug policies and renewed scientific, medical, spiritual, and public interest in psychedelic substances. They define “psychedelics” broadly to include LSD, psilocybin, MDMA, DMT, ayahuasca, peyote, mescaline and related tryptamine and phenethylamine compounds. After noting that other normative frameworks (for example, religious freedom and human-rights or cognitive-liberty arguments) have been used to justify alternative legal treatment of psychedelics, the authors explain that their purpose is to examine regulation and management through a public-health lens. The paper aims to summarise recent research on psychedelics and then propose a public-health-based regulatory model for their production, distribution, supervision and use. The proposed model draws on prior work by the Health Officers Council of British Columbia and lessons from regulatory approaches to alcohol, tobacco and cannabis, with particular attention to governance, supervision, controls on set and setting, youth access, supply management, demand mitigation and monitoring/evaluation.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typemeta
- Journal
- Topics
- Author
- APA Citation
Haden, M., Emerson, B., & Tupper, K. W. (2016). A Public-Health-Based Vision for the Management and Regulation of Psychedelics. Journal of Psychoactive Drugs, 48(4), 243-252. https://doi.org/10.1080/02791072.2016.1202459
References (33)
Papers cited by this study that are also in Blossom
Abraham, H. D., Aldridge, A. M., Gogia, P. · Neuropsychopharmacology (1996)
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A. et al. · Journal of Psychopharmacology (2015)
Brown, T. K. · Current Drug Abuse Reviews (2013)
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M. et al. · Psychological Medicine (2016)
Carvalho, J., Carvalho, M., de Sousa, M. P. et al. · Current Drug Abuse Reviews (2015)
Griffiths, R. R. · Journal of Psychopharmacology (2008)
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Grob, C. S., Danforth, A. L., Chopra, G. S. et al. · JAMA Psychiatry (2011)
Halpern, J. H., Pope Jr, H. G. · Drug and Alcohol Dependence (1999)
Halpern, J. H., Pope Jr, H. G. · Drug and Alcohol Dependence (2003)
Show all 33 referencesShow fewer
Halpern, J. H., Sherwood, A. R., Passie, T. et al. · Medical Science Monitor (2008)
Hendricks, P. S., Clark, B., Johnson, M. W. et al. · Journal of Psychopharmacology (2014)
Hendricks, P. S., Thorne, C. B., Clark, B. et al. · Journal of Psychopharmacology (2015)
Johansen, P. Ø., Krebs, T. S. · Journal of Psychopharmacology (2015)
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P. et al. · Journal of Psychopharmacology (2014)
Krebs, T. S., Johansen, P. Ø. · Journal of Psychopharmacology (2012)
Krebs, T. S., Johansen, P. ˚. Ø. · PLOS ONE (2013)
Goodman, L. E., Grof, S., Kurland, A. A. et al. · Journal of Death and Dying (1972)
Maclean, K. A., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2011)
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T. et al. · Journal of Psychopharmacology (2010)
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T. et al. · Journal of Psychopharmacology (2012)
Moreno, F. A., Wiegand, C. B., Taitano, E. K. et al. · Journal of Clinical Psychiatry (2006)
King, C., Nichols, D. E. · Nature Reviews Neuroscience (2013)
Pahnke, W. N. · Psychedelic Review (1969)
Sanches, R. F., Osório, F. L., Dos Santos, R. G. et al. · Journal of Clinical Psychopharmacology (2016)
Schenberg, E. E., de Castro Comis, M. A., Chaves, T. V. et al. · Journal of Psychopharmacology (2014)
Sessa, B. · British Journal of Psychiatry (2018)
Sewell, R. A. · Neurology (2006)
Thomas, G., Lucas, P., Rielle Capler, N. et al. · Current Drug Abuse Reviews (2013)
Tupper, K. W., Wood, E., Yensen, R. et al. · Canadian Medical Association Journal (2015)
Walsh, C. · International Journal of Drug Policy (2016)
Walsh, Z., Hendricks, P. S., Smith, S. et al. · Journal of Psychopharmacology (2016)
Cited By (2)
Papers in Blossom that reference this study
Arnaud, K. O. S. · Drugs Education Prevention and Policy (2021)
Williams, M. L., Korevaar, D., Harvey, R. et al. · Frontiers in Psychiatry (2021)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.